Recruiting
GD2/CD56 Bi-specific CAR-T Cell Therapy
NCT05437328
- Conditions
- Malignant Disease, Neoplasms
- Locations
-
- Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
Clinical trial condition
Explore clinical trials studying Malignant Disease. Study availability and eligibility vary by location and protocol.
NCT05437328
NCT00881166
NCT02447237
NCT03560882